Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-m ethyl3-(4-pyridin-3-yl)pyrimidin-2-ylamino)ph enyl]-benzamide

Details for Australian Patent Application No. 2005211514 (hide)

Owner Novartis AG

Inventors Manley, Paul William; Mutz, Michael; Burger, Hans Michael

Agent Davies Collison Cave

Pub. Number AU-B-2005211514

PCT Pub. Number WO2005/075454

Priority 60/541,817 04.02.04 US

Filing date 3 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 10 September 2009

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/075454 Priority application(s): WO2005/075454

10 September 2009 Application Accepted

  Published as AU-B-2005211514

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211516-Cooking Tool Keeper/Holder

2005211504-Fluid polyester moulding masses